Expanded access may provide access for treatment prior to approval by the local regulatory agency. For full details, please visit the link provided.
Other Name: UX023
Other Name: Crysvita®
Other Name: KRN23
Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.